BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34849011)

  • 1. Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores.
    Xie H; Zhang JF; Li Q
    Int J Gen Med; 2021; 14():8677-8688. PubMed ID: 34849011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of prognosis of patients with hepatocellular carcinoma based on immune-related score.
    Song XQ; Li RJ; Zhang S
    Asian J Surg; 2024 Jan; 47(1):310-319. PubMed ID: 37673742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic nomogram based on immune scores for breast cancer patients.
    Wang J; Li Y; Fu W; Zhang Y; Jiang J; Zhang Y; Qi X
    Cancer Med; 2019 Sep; 8(11):5214-5222. PubMed ID: 31342666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer.
    Qi X; Fu Y; Zhang M; Lu C; Wang Y; Peng J; Li G
    Biomed Res Int; 2020; 2020():8882576. PubMed ID: 33224983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Nomogram Based on Immune Scores for Predicting Survival in Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC).
    Wu Z; Ouyang C; Peng L
    Med Sci Monit; 2020 Jun; 26():e923231. PubMed ID: 32479428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
    Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
    BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of RNA editing profiles in lung adenocarcinoma.
    Shi S; Chen S; Wang M; Guo B; He Y; Chen H
    Front Genet; 2023; 14():1084869. PubMed ID: 36999050
    [No Abstract]   [Full Text] [Related]  

  • 10. A new clinical prognostic nomogram for liver cancer based on immune score.
    Shen Q; Hu G; Wu J; Lv L
    PLoS One; 2020; 15(7):e0236622. PubMed ID: 32730361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma.
    Jin D; Song Y; Chen Y; Zhang P
    Biomed Res Int; 2020; 2020():7929132. PubMed ID: 32596372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Immune Implication and Prognostic Value of
    Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
    Front Oncol; 2021; 11():798425. PubMed ID: 35047409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
    Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
    BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
    Li C; Long Q; Zhang D; Li J; Zhang X
    BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prognostic Nomogram Based on Immune Scores Predicts Postoperative Survival for Patients with Hepatocellular Carcinoma.
    Wang J; Zhang C; Li A; Cao F; Liu D; Li F; Luo T
    Biomed Res Int; 2020; 2020():1542394. PubMed ID: 32724794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.